scholarly article | Q13442814 |
P50 | author | Rejko Krüger | Q30500739 |
Olaf Riess | Q83912532 | ||
Hartwig Wolburg | Q32419952 | ||
P2093 | author name string | Dirk Woitalla | |
Tassula Proikas-Cezanne | |||
Brigitte Maurer | |||
Zemfira Gizatullina | |||
Jens Waak | |||
Philipp J. Kahle | |||
Frank N. Gellerich | |||
Nicole Kieper | |||
Guido Krebiehl | |||
Lena F. Burbulla | |||
Sabine Ruckerbauer | |||
P2860 | cites work | Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes | Q23757358 |
DJ-1 has a role in antioxidative stress to prevent cell death | Q24306633 | ||
Human WIPI-1 puncta-formation: a novel assay to assess mammalian autophagy | Q24318098 | ||
High levels of Fis1, a pro-fission mitochondrial protein, trigger autophagy | Q24318282 | ||
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism | Q24321359 | ||
WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is aberrantly expressed in human cancer and is linked to starvation-induced autophagy | Q24322858 | ||
Mitochondrial localization of DJ-1 leads to enhanced neuroprotection | Q24324226 | ||
Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | Q24337084 | ||
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy | Q24652230 | ||
Selective degradation of mitochondria by mitophagy | Q24658163 | ||
Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death | Q24676936 | ||
Formation of a Stabilized Cysteine Sulfinic Acid Is Critical for the Mitochondrial Function of the Parkinsonism Protein DJ-1 | Q27653346 | ||
Autophagy fights disease through cellular self-digestion | Q27860902 | ||
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice | Q28131756 | ||
Pathways to Parkinsonism | Q28202942 | ||
A block of autophagy in lysosomal storage disorders | Q28252016 | ||
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease | Q28257086 | ||
The roles of intracellular protein-degradation pathways in neurodegeneration | Q28269322 | ||
C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging | Q28472271 | ||
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. | Q28593258 | ||
How to interpret LC3 immunoblotting | Q29614175 | ||
Autophagy genes are essential for dauer development and life-span extension in C. elegans | Q29614180 | ||
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants | Q29615627 | ||
The PINK1/Parkin pathway regulates mitochondrial morphology | Q29615641 | ||
Disruption of fusion results in mitochondrial heterogeneity and dysfunction | Q29616566 | ||
Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin | Q29617063 | ||
The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila | Q29617091 | ||
Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin | Q29622838 | ||
Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy | Q30489519 | ||
Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells | Q67902824 | ||
Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome | Q71106292 | ||
Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution | Q73216536 | ||
Energetic depression caused by mitochondrial dysfunction | Q76377719 | ||
DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism | Q79249169 | ||
Lysosomal storage diseases as disorders of autophagy | Q79827971 | ||
Structural determinants of the C-terminal helix-kink-helix motif essential for protein stability and survival promoting activity of DJ-1 | Q79855134 | ||
Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells | Q33341058 | ||
Complex patterns of mitochondrial dynamics in human pancreatic cells revealed by fluorescent confocal imaging | Q33433158 | ||
Autophagosome formation in mammalian cells | Q33964242 | ||
Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection | Q33998125 | ||
A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases | Q34628278 | ||
ROS, mitochondria and the regulation of autophagy | Q34679713 | ||
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization | Q34836156 | ||
Mitophagy in yeast occurs through a selective mechanism | Q34837659 | ||
Present and future drug treatment for Parkinson's disease | Q35484805 | ||
Mitochondria take center stage in aging and neurodegeneration | Q36264218 | ||
Signalling and autophagy regulation in health, aging and disease | Q36594286 | ||
Impact of recent genetic findings in Parkinson's disease | Q36874881 | ||
Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson's disease | Q36952897 | ||
Regulation of mitochondrial fusion and division | Q36980993 | ||
DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses | Q37061628 | ||
Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes. | Q37079467 | ||
Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease | Q37126849 | ||
Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease | Q37151410 | ||
Mitochondrial dysfunction in neurodegenerative diseases. | Q37322156 | ||
Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models | Q37356319 | ||
Turnover of organelles by autophagy in yeast | Q37514587 | ||
Mitochondria and energetic depression in cell pathophysiology | Q37535535 | ||
Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. | Q39704890 | ||
Silencing DJ-1 reveals its contribution in paraquat-induced autophagy. | Q39854932 | ||
Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress | Q39860196 | ||
Assessing mammalian autophagy by WIPI-1/Atg18 puncta formation. | Q39886256 | ||
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). | Q40515980 | ||
In search of an "autophagomometer". | Q46027342 | ||
Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease | Q46683999 | ||
Mitochondrial aberrations in mucolipidosis Type IV. | Q48390239 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Parkinson's disease | Q11085 |
mitochondrion | Q39572 | ||
autophagy | Q288322 | ||
Parkinson disease (autosomal recessive, early onset) 7 | Q21989850 | ||
P304 | page(s) | e9367 | |
P577 | publication date | 2010-02-23 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1 | |
P478 | volume | 5 |
Q89747676 | A co-culture nanofibre scaffold model of neural cell degeneration in relevance to Parkinson's disease |
Q38211382 | A mitocentric view of Parkinson's disease. |
Q34211127 | A mitochondrial etiology of Alzheimer and Parkinson disease |
Q38948943 | A new split-GFP-based probe reveals DJ-1 translocation into the mitochondrial matrix to sustain ATP synthesis upon nutrient deprivation |
Q50356424 | A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network. |
Q36890227 | AF-MSCs fate can be regulated by culture conditions |
Q28116275 | ATP13A2 regulates mitochondrial bioenergetics through macroautophagy |
Q37136665 | Activation of Mitochondrial Complex II-Dependent Respiration Is Beneficial for α-Synucleinopathies. |
Q37221070 | Advances with microRNAs in Parkinson's disease research |
Q36608779 | Altered Skeletal Muscle Mitochondrial Proteome As the Basis of Disruption of Mitochondrial Function in Diabetic Mice |
Q52591608 | Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease. |
Q39301296 | Autophagy is a cell self-protective mechanism against arsenic-induced cell transformation |
Q28390830 | Autophagy is a protective response to ethanol neurotoxicity |
Q37782121 | Balance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease |
Q35510313 | Bioenergetic origins of complexity and disease |
Q42133537 | CHIP Is an Essential Determinant of Neuronal Mitochondrial Stress Signaling |
Q34770689 | Cucurbitacin E has neuroprotective properties and autophagic modulating activities on dopaminergic neurons |
Q93108820 | Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease |
Q39978117 | Cyclosporine A Treatment Abrogates Ischemia-Induced Neuronal Cell Death by Preserving Mitochondrial Integrity through Upregulation of the Parkinson's Disease-Associated Protein DJ-1. |
Q34399382 | DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy |
Q47786526 | DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia. |
Q48131019 | DJ-1 deficiency impairs synaptic vesicle endocytosis and reavailability at nerve terminals. |
Q30527966 | DJ-1 knock-down impairs astrocyte mitochondrial function |
Q34189590 | DJ-1 null dopaminergic neuronal cells exhibit defects in mitochondrial function and structure: involvement of mitochondrial complex I assembly |
Q39416502 | DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. |
Q37620686 | DJ-1 protects against cell death following acute cardiac ischemia-reperfusion injury. |
Q26785491 | Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose |
Q38225786 | Defective autophagy in Parkinson's disease: lessons from genetics |
Q38035191 | Defective autophagy in Parkinson's disease: role of oxidative stress. |
Q34428732 | Defects in mitochondrial fission protein dynamin-related protein 1 are linked to apoptotic resistance and autophagy in a lung cancer model |
Q34538482 | Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases. |
Q35819806 | Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis |
Q36579655 | Distinct roles in autophagy and importance in infectivity of the two ATG4 cysteine peptidases of Leishmania major |
Q34985943 | Diversity in the regulation of autophagy and mitophagy: lessons from Parkinson's disease. |
Q46310564 | Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease |
Q33705939 | Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4. |
Q28071890 | Dysregulation of autophagy and mitochondrial function in Parkinson's disease |
Q46783933 | Effects of stimulation of autophagy on the urinary excretion of biomarkers of the oxidative status |
Q26795417 | Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics |
Q34078603 | Engineered disulfide bonds restore chaperone-like function of DJ-1 mutants linked to familial Parkinson's disease |
Q41918404 | Established Principles and Emerging Concepts on the Interplay between Mitochondrial Physiology and S-(De)nitrosylation: Implications in Cancer and Neurodegeneration. |
Q28258696 | Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1 |
Q44435362 | Evidence of oxidative stress in young and aged DJ-1-deficient mice. |
Q60695461 | Exploring the Role of Autophagy in the Pathogenesis of Rotenone-induced Toxicity |
Q47393162 | Expression of DJ-1 in Neurodegenerative Disorders |
Q30901756 | Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. |
Q97527088 | Fine-mapping within eQTL credible intervals by expression CROP-seq |
Q38933311 | Fluorescence-based imaging of autophagy progression by human WIPI protein detection. |
Q51033505 | Free radicals impair the anti-oxidative stress activity of DJ-1 through the formation of SDS-resistant dimer. |
Q94586186 | Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis |
Q26852964 | Genetically engineered mouse models of Parkinson's disease |
Q42368121 | Hexokinases link DJ-1 to the PINK1/parkin pathway |
Q28392567 | How Parkinsonian toxins dysregulate the autophagy machinery |
Q34800994 | Identification of the recognition sequence and target proteins for DJ-1 protease |
Q34321143 | Inhibition of mitochondria- and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells |
Q36675381 | Integration of cellular bioenergetics with mitochondrial quality control and autophagy |
Q36711438 | Ketamine enhances human neural stem cell proliferation and induces neuronal apoptosis via reactive oxygen species-mediated mitochondrial pathway |
Q83204494 | Lipocalin 2 deficiency inhibits cell proliferation, autophagy, and mitochondrial biogenesis in mouse embryonic cells |
Q34336431 | Loss of DJ-1 does not affect mitochondrial respiration but increases ROS production and mitochondrial permeability transition pore opening |
Q36714253 | Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit |
Q33727623 | Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia |
Q33627056 | Metabolic role for yeast DJ-1 superfamily proteins |
Q37889815 | Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease |
Q47147993 | Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson's Disease |
Q58575955 | Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3 |
Q55081064 | Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease. |
Q57155833 | Mitochondrial Targeting in Neurodegeneration: A Heme Perspective |
Q39295078 | Mitochondrial accumulation under oxidative stress is due to defects in autophagy. |
Q93113555 | Mitochondrial biology in airway pathogenesis and the role of NRF2 |
Q37891820 | Mitochondrial contribution to Parkinson's disease pathogenesis |
Q38811534 | Mitochondrial control of cell bioenergetics in Parkinson's disease. |
Q28280353 | Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease |
Q38237889 | Mitochondrial dynamic changes in health and genetic diseases |
Q35799161 | Mitochondrial dynamics and Parkinson's disease: focus on parkin |
Q41664833 | Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein? |
Q36082495 | Mitochondrial dynamics in cancer and neurodegenerative and neuroinflammatory diseases |
Q38021396 | Mitochondrial dynamics: the intersection of form and function |
Q27014051 | Mitochondrial dysfunction and oxidative stress in Parkinson's disease |
Q36590693 | Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism |
Q58693945 | Mitochondrial dysfunction in Parkinson's disease |
Q38021865 | Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences |
Q90306382 | Mitochondrial fragmentation and network architecture in degenerative diseases |
Q92365106 | Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients |
Q37726096 | Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1. |
Q35799128 | Mitochondrial quality control and dynamics in Parkinson's disease |
Q28395762 | Mitochondrial stress signaling promotes cellular adaptations |
Q92129107 | Mitophagy in Parkinson's Disease: From Pathogenesis to Treatment |
Q37957494 | Modelling of Parkinson's disease in mice |
Q36747314 | Molecular events underlying Parkinson's disease - an interwoven tapestry |
Q34988753 | Molecular insights into Parkinson's disease |
Q34552123 | Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants |
Q91859559 | Mutations in RHOT1 Disrupt Endoplasmic Reticulum-Mitochondria Contact Sites Interfering with Calcium Homeostasis and Mitochondrial Dynamics in Parkinson's Disease |
Q64110751 | Natrium Benzoate Alleviates Neuronal Apoptosis via the DJ-1-Related Anti-oxidative Stress Pathway Involving Akt Phosphorylation in a Rat Model of Traumatic Spinal Cord Injury |
Q36899553 | Neuroprotective function of DJ-1 in Parkinson's disease |
Q44083491 | Novel glyoxalases from Arabidopsis thaliana |
Q24337858 | Nuclear translocation of DJ-1 during oxidative stress-induced neuronal cell death |
Q26798897 | Oxidative stress and Parkinson's disease |
Q42416499 | Oxygen-glucose-deprived rat primary neural cells exhibit DJ-1 translocation into healthy mitochondria: a potent stroke therapeutic target |
Q61875301 | Paraquat: Molecular Mechanisms of Neurotoxicity and its Relation with Autophagy |
Q26781796 | Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection |
Q37087927 | Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction |
Q40393851 | Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells. |
Q35032823 | Parkinson's disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein. |
Q33871291 | Parkinson's disease: insights from pathways |
Q36186542 | Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways |
Q37497833 | Pharmacological approaches to restore mitochondrial function |
Q38036233 | Programmed cell death in Parkinson's disease |
Q36939061 | Proteome Profile and Quantitative Proteomic Analysis of Buffalo (Bubalusbubalis) Follicular Fluid during Follicle Development |
Q37502060 | Proteomic Analysis Reveals the Positive Roles of the Plant-Growth-Promoting Rhizobacterium NSY50 in the Response of Cucumber Roots to Fusarium oxysporum f. sp. cucumerinum Inoculation |
Q90102147 | Reactive Metabolite-induced Protein Glutathionylation: A Potentially Novel Mechanism Underlying Acetaminophen Hepatotoxicity |
Q34189660 | Recent advances in the genetics of Parkinson's disease |
Q58716523 | Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contacts |
Q47393112 | Regulation of Signal Transduction by DJ-1. |
Q38264531 | Regulation of autophagy by protein post-translational modification |
Q37998247 | Review: quantifying mitochondrial dysfunction in complex diseases of aging. |
Q96953595 | Role of DJ-1 in Immune and Inflammatory Diseases |
Q64980081 | Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease. |
Q64762196 | Role of GTPases in the regulation of mitochondrial dynamics in Parkinson's disease |
Q38757045 | SUMO-regulated mitochondrial function in Parkinson's disease |
Q35857121 | Schizosaccharomyces pombe Homologs of Human DJ-1 Are Stationary Phase-Associated Proteins That Are Involved in Autophagy and Oxidative Stress Resistance |
Q38769351 | The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity |
Q55384244 | The Oxygen Paradox, the French Paradox, and age-related diseases. |
Q38374332 | The Parkinson Disease Mitochondrial Hypothesis: Where Are We at? |
Q48158987 | The Parkinson disease-related protein DJ-1 counteracts mitochondrial impairment induced by the tumour suppressor protein p53 by enhancing endoplasmic reticulum-mitochondria tethering |
Q39138747 | The Parkinson's disease-associated gene PINK1 protects neurons from ischemic damage by decreasing mitochondrial translocation of the fission promoter Drp1. |
Q35031181 | The Role of Cysteine Oxidation in DJ-1 Function and Dysfunction |
Q64069200 | The Role of the Antioxidant Response in Mitochondrial Dysfunction in Degenerative Diseases: Cross-Talk between Antioxidant Defense, Autophagy, and Apoptosis |
Q38202314 | The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease |
Q26853454 | The dynamics of the mitochondrial organelle as a potential therapeutic target |
Q47646796 | The genetic architecture of mitochondrial dysfunction in Parkinson's disease |
Q38016276 | The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease |
Q34807191 | The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble |
Q95650650 | The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges |
Q24307946 | The role of oxidative stress in Parkinson's disease |
Q36375135 | The use of primary human fibroblasts for monitoring mitochondrial phenotypes in the field of Parkinson's disease |
Q39264622 | Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson's disease genes |
Q37704828 | Two novel compound heterozygous mutations in OPA3 in two siblings with OPA3-related 3-methylglutaconic aciduria |
Q37775037 | Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy |
Q51716269 | Unexpected mitochondrial matrix localization of Parkinson's disease-related DJ-1 mutants but not wild-type DJ-1. |
Q34201811 | Unravelling the role of defective genes |
Q92328689 | Variants in Miro1 Cause Alterations of ER-Mitochondria Contact Sites in Fibroblasts from Parkinson's Disease Patients |
Q37796006 | What have we learned from Drosophila models of Parkinson’s disease? |
Q27937729 | Yeast DJ-1 superfamily members are required for diauxic-shift reprogramming and cell survival in stationary phase |
Q40986110 | αSynuclein control of mitochondrial homeostasis in human-derived neurons is disrupted by mutations associated with Parkinson's disease. |